Report Archive
All Research
Page 38 of 44 · 1035 reports
48/100
DexCom Investment Research Report
DexCom is one of the global leaders in continuous glucose monitoring (CGM), with long-term demand tailwinds and strong cash conversion. The core thesis is that this is a high-quality recurring-consumables medical device business, but the current price of $71.9 implies about 30.9x P/E and sits close to fair intrinsic value of $65-$75, while Abbott competition and the FDA warning letter leave limited margin of safety. Research rating Watch: a durable compounder candidate that deserves long-term tracking, but not yet a clearly discounted buy.
52/100
Datadog: A Value Investing Deep Dive
A high-quality cloud observability platform with 30% growth and strong cash flow, but at the current 218.04 dollars it trades 56%-129% above a fair intrinsic value of 95-140 dollars, leaving no margin of safety. Rating Watch: an excellent business whose price already prices in years of flawless execution.
46/100
Cintas Corporation Long-Term Owner's Perspective Research
Cintas is a high-quality business with a deep route-density moat, strong cash flow, and ROIC still improving from a high base. At the current price of $172.36, roughly 35.6x TTM earnings, my conservative intrinsic value range of only $100-130 makes it look more like a hold price than an undervalued entry point. Report rating Watch: an excellent company, but today's price does not offer a clear margin of safety.
42/100
CSX Corporation: A Deep-Dive Value Investing Study
One of the two Eastern rail duopolists, with a deep moat and strong cash flow; but at $45.9 the stock trades at 28.2x PE while fair value is only $26–34, a 35%–75% premium that leaves an insufficient margin of safety. Rating: Watch.
45/100
Cisco Systems: A Value-Investing Deep Dive
An understandable, cash-generative network-infrastructure platform, but at the current $118.20 it is priced like an AI growth stock (about 46x P/E); fair intrinsic value is only $60–80, the margin of safety is insufficient, rating Watch.
30/100
Bitmine Immersion Technologies: A Deep Value Study
BMNR is a high-beta ETH treasury stock loaded with fees, dilution, and governance risk rather than a high-quality compounder; adjusted EBITDA is still negative and the share count expanded roughly 125x in under a year. At a current price of $19.61, the stock trades at a modest discount to a reasonable intrinsic value of $21–25, but it is not cheap enough. Rating Watch: an asset-driven ETH proxy trading below company-stated holdings, yet short on business quality, governance discipline, and a real margin of safety.
42/100
ASE Technology Holding: An In-Depth Value Investing Study
The world's largest semiconductor packaging-and-testing (OSAT) leader, with advanced packaging benefiting from AI; 2026Q1 revenue rose +17% YoY and net profit +87%, but its capital-heavy, cyclical character is pronounced and the stock is already up 95% year-to-date, leaving an insufficient margin of safety; rating Watch.
50/100
Airbnb Value Investment Deep-Dive
Airbnb is a high-quality, cash-generative, asset-light platform business. At roughly $135.84, however, the stock lacks a sufficient margin of safety, with fair intrinsic value estimated at $135 to $165 and an ideal buy range of $95 to $115. Rating Watch: a durable platform worth following closely, but current pricing leaves limited downside protection for conservative value investors.
56/100
Innolight (Zhongji Innolight): A Deep Value Investment Study
Rating Watch. The world's number-one leader in high-speed AI optical modules, with 2025 net profit attributable to shareholders of 10.797 billion yuan and a durable moat. But at roughly 1,037 yuan the current price already sits above the 700-950 yuan upper bound of an optimistic intrinsic value, at about 77x PE, leaving no margin of safety. Rating Watch: a superb business priced for a decade of optimistic growth, not a purchase with downside protection.
46/100
Eoptolink Research from a Long-Term Business Owner's Perspective
Eoptolink is a global leader in high-speed optical modules for 800G and 1.6T AI data-center interconnects. Net profit reached RMB 9.5 billion in 2025 with extremely strong growth, but overseas revenue accounts for 96%, customer concentration is high, cash flow is uneven, and the current RMB 567 share price is far above the upper end of the optimistic intrinsic value range of RMB 320 to RMB 420, leaving no margin of safety. Rating Watch: a high-quality company whose valuation already prices in too much optimism.
48/100
Kweichow Moutai: A Long-Term Business Owner's Perspective
Kweichow Moutai remains one of the scarcest consumer cash machines in China's A-share market, with gross margin above 91%, ROE above 30%, and RMB 65.0 billion in dividends for 2025. The core thesis is strong business quality but limited margin of safety, as the liquor industry is in an adjustment phase and the current price of about RMB 1,311 sits near the upper end of the RMB 1,150 to RMB 1,350 fair-value range. Research rating Watch: a great business, but not yet an obviously cheap entry point.
41/100
Dongfang Electric: A Long-Term Business Owner's Perspective
China's platform-scale leader in power-generation equipment, spanning thermal, hydro, nuclear, gas, wind, and solar with sustained order growth. Free cash flow trails accounting profit meaningfully, and the A-share price at roughly 33x P/E already prices in improvement in heavy-duty gas turbines and nuclear power, leaving no margin of safety. Rating: Watch.
21/100
HYLink Digital: A Long-Term Owner's Investment Analysis
Rating Avoid. Revenue has shrunk roughly 90% over four years, the company has posted four straight years of losses, and net assets are nearly depleted, with a regulatory record of related-party fund occupation and false disclosure. At 8.43 yuan, the current price sits far above an intrinsic value range of 0.2-5.5 yuan; this is a state-capital turnaround option, not a proven compounder. Rating Avoid: a governance-impaired, balance-sheet-fragile restructuring story already pricing in a transformation option.
43/100
Western Superconducting: A Long-Term Enterprise Value Analysis
A niche leader in high-end titanium alloys, low-temperature superconductors, and high-performance superalloys, with genuine certification and process barriers; but free cash flow is markedly weaker than accounting profit, governance drew regulatory warnings over the past two years, and a PE (TTM) of about 57x overpays for growth expectations, leaving no margin of safety. Rating: Watch.
44/100
Agilent Technologies: A Study from a Long-Term Business Owner's Perspective
A high-quality laboratory tools and services company whose CrossLab services/consumables franchise is highly sticky, with solid cash flow and low debt. At the current $113.78, mid-single-digit growth is already fully priced in and the margin of safety is insufficient; rating Watch, with an ideal buy zone of $70-85.
45/100
AbbVie: In-Depth Research from a Long-Term Business Owner's Perspective
AbbVie has cleared the Humira patent cliff, with Skyrizi/Rinvoq taking over as twin engines (together about 42% of 2025 revenue), backed by strong cash flow and a solid dividend; at the current $212.30 the margin of safety is thin and book equity is negative, so the rating is Watch, with an ideal buy range of $155-180.
47/100
Abbott Laboratories Long-Term Value Investment Research
Abbott Laboratories is a high-quality healthcare company powered by four engines: medical devices, diagnostics, nutrition, and established pharmaceuticals. Its cash generation is solid and its dividend has risen for 54 consecutive years, but the current price of USD 88.38 offers limited margin of safety while the Exact Sciences acquisition raises leverage. Rating Watch: an attractive long-term compounder, but the ideal buy zone is USD 70-80.
45/100
Arch Capital Group Ltd. Deep Value Research
A high-quality insurer built on disciplined underwriting and multi-platform diversification, with book value per share compounding at roughly 16% CAGR over six years and sustained buybacks accreting per-share value. At about $95.87 it trades near 1.45x book, reasonable but only slightly cheap, with a limited margin of safety. Rated Cautious Buy, with an ideal buy range of $80-90.
48/100
Adobe Investment Research from a Long-Term Business Owner's Perspective
Adobe is a high-quality subscription software platform across creative, document, and marketing workflows, with gross margins near 90%, very strong cash flow, and net leverage close to zero. The company is being repriced for AI risk, while the current price of $253.37 is roughly 10x free cash flow and the ideal buy range is $220-280. Research rating Cautious Buy: a durable compounder with improved odds, but not enough margin of safety for an indiscriminate large position.
49/100
Analog Devices Deep Value Investment Research
Analog Devices is a high-quality analog semiconductor leader, with industrial and automotive contributing 75% of revenue and cash flow that has long exceeded accounting earnings. The core thesis is that the business is excellent, but the current price of about $398.05 implies roughly 43 times conservative owner earnings and leaves valuation far ahead of fundamentals. Research rating Watch: a durable compounder worth tracking closely, with an ideal buy zone of $150 to $200.
52/100
Autodesk: A Deep Value Investment Analysis
A high-stickiness leader in professional design software, with FY2026 recurring revenue at 97% of total and free cash flow of 2.4 billion dollars. But at roughly 244 dollars the stock sits in the optimistic zone, SBC erodes true earnings, and the margin of safety is thin. Rating Watch: a high-quality compounder priced for optimism rather than safety; ideal buy range 140-180 dollars.
40/100
American Electric Power In-Depth Value Investment Analysis
A high-quality regulated grid leader, but the 2026-2030 $78 billion capital plan relies heavily on equity financing and dilution risk is real; at about $129 it lacks a margin of safety, with an ideal entry range of $95-110.
47/100
Alnylam Pharmaceuticals Deep Value Investment Analysis
Alnylam is an RNAi innovator that reached its first full-year profit in 2025, with AMVUTTRA driving rapid commercialization. The core thesis is that the business has moved beyond a platform story, but revenue concentration, SBC, and financing complexity leave limited margin of safety at about $299. Research rating Watch: a durable company may be emerging, but an ideal entry point is closer to $200-240.
48/100
Applied Materials Deep Value Investment Research
Applied Materials is a leading semiconductor equipment company with the broadest product portfolio, an AGS service business that strengthens recurring revenue, and a net-cash balance sheet with strong cash flow. The core thesis is that business quality is high, but the current price of USD 426.85 at roughly 44x PE has already pulled forward too much AI-cycle optimism. Report rating Watch: the ideal buy range is USD 140-190.